AHRQ Patient Safety Network

Skip Navigation

The Collection > Food and Drug Administration (FDA)

Narrow By

clear selections

Safety Target

•Device-related Complications (21)

•Diagnostic Errors (2)

•Discontinuities, Gaps, and Hand-Off Problems (1)

•Medication Safety (68)

•Medical Complications (3)

•Nonsurgical Procedural Complications (4)

•Surgical Complications (4)

Origin/Sponsor
< All

Food and Drug Administration (FDA)

Resource Types

•Audiovisual (9)

•Book/Report (1)

•Journal Article (3)

•Legislation/Regulation (3)

•Meeting/Conference (3)

•Newspaper/Magazine Article (1)

•Press Release/Announcement (43)

•Tools/Toolkit (6)

•Web Resource (17)

Error Types

•Epidemiology of Errors and Adverse Events (2)

•Active Errors (17)

•Latent Errors (12)

•Near Miss (1)

Approach to Improving Safety

•Quality Improvement Strategies (21)

•Legal and Policy Approaches (4)

•Error Reporting and Analysis (14)

•Communication Improvement (13)

•Human Factors Engineering (23)

•Technologic Approaches (6)

•Education and Training (22)

Clinical Areas

•Medicine (51)

•Pharmacy (37)

Target Audience

•Health Care Providers (72)

•Health Care Executives and Administrators (37)

•Non-Health Care Professionals (16)

•Patients (39)

Setting of Care

•Hospitals (7)

•Ambulatory Care (11)

1 - 20 of 86

Show ExcerptDon't Show Excerpt

dropdown

PRESS RELEASE/ANNOUNCEMENT

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; June 13, 2011.

PRESS RELEASE/ANNOUNCEMENT

Serious medication errors from intravenous administration of nimodipine oral capsules.

MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; August 2, 2010.

MEETING/CONFERENCE PROCEEDINGS

Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors.

US Food and Drug Administration. June 24–25, 2010; Marriott Residence Inn, Bethesda, MD.

PRESS RELEASE/ANNOUNCEMENT

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

FDA Alert [US Food and Drug Administration Web site]. March 19, 2009.

PRESS RELEASE/ANNOUNCEMENT

Edetate Disodium (marketed as Endrate and generic products).

FDA Public Health Advisory [US Food and Drug Administration Web site]. January 16, 2008.

PRESS RELEASE/ANNOUNCEMENT

Important change to heparin container labels to clearly state the total drug strength.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; December 6, 2012.

FACT SHEET/FAQS

Ten Tips to Prevent an Accidental Overdose.

Silver Spring, MD: US Food and Drug Administration; May 2011.

AUDIOVISUAL PRESENTATION

Preventing Medical Errors.

Food and Drug Administration (FDA) Patient Safety News. Show #79. September 2008.

FACT SHEET/FAQS

FDA 101: Medication Errors.

FDA Consumer Health Information. Rockville, MD: US Food and Drug Administration; February 20, 2009.

PRESS RELEASE/ANNOUNCEMENT

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; August 13, 2009.

PRESS RELEASE/ANNOUNCEMENT

Roxane Laboratories Initiates a Nationwide Voluntary Recall of a Single Manufacturing Lot of Azathioprine Tablets in the U.S. and Puerto Rico.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; July 13, 2006.

AUDIOVISUAL

Avoiding Medication Mistakes.

Fitzpatrick C. Consumer Updates. Silver Spring, MD: US Food and Drug Administration. September 29, 2009.

PRESS RELEASE/ANNOUNCEMENT

Promethazine HCl (marketed as Phenergan) Information.

FDA Alert [US Food and Drug Administration Web site]. April 25, 2006.

PRESS RELEASE/ANNOUNCEMENT

Vitamin D supplement products: medication use error.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; June 15, 2010.

DATABASE/DIRECTORY

Medication-related FDA patient safety videos provided in cooperation with ISMP.

Horsham, PA: Institute for Safe Medication Practices; 2011.

MULTI-USE WEBSITE

Human Factors and Medical Devices.

Human Factors Engineering Team, Center for Devices and Radiological Health, Office of Communication, Education, and Radiation Programs (OCER), Division of Device User Programs and Systems Analysis (DDUPSA), 1350 Piccard Drive, HFZ-230, Rockville, MD 20850.

MEETING/CONFERENCE PROCEEDINGS

An Introduction to the Improved FDA Prescription Drug Labeling.

US Food and Drug Administration Center for Drug Evaluation and Research, Institute for Safe Medication Practices. November 7, 2006.

PRESS RELEASE/ANNOUNCEMENT

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 7, 2011.

PRESS RELEASE/ANNOUNCEMENT

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 10, 2011.

PRESS RELEASE/ANNOUNCEMENT

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 6, 2007.

1 2 3 4 5 Next >